We are live on ! Find out more
DBIA

Dumont & Blake Investment Advisors Portfolio holdings

AUM $445M
1-Year Est. Return 31.98%
This Fund
S&P 500
This Quarter Est. Return
-4.79%
1 Year Est. Return
+31.98%
3 Year Est. Return
+78.27%
5 Year Est. Return
+88.91%
10 Year Est. Return
+293.66%
AUM
$267M
AUM Growth
-$38.9M
Cap. Flow
-$24.7M
Cap. Flow %
-9.25%
Top 10 Hldgs %
35.92%
Holding
206
New
4
Increased
61
Reduced
101
Closed
15

Sector Composition

Rank Sector Weight
1 Technology 10.89%
2 Financials 7.82%
3 Healthcare 7.57%
4 Consumer Discretionary 4.95%
5 Consumer Staples 4.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMGN icon
26
Amgen
AMGN
$222B
$2.18M 0.82%
9,661
-775
-7% -$188K
WMT icon
27
Walmart Inc
WMT
$890B
$2.17M 0.81%
50,295
-3,006
-6% -$132K
JPM icon
28
JPMorgan Chase
JPM
$950B
$2.13M 0.8%
20,388
+661
+3% +$75.9K
BLK icon
29
Blackrock
BLK
$176B
$2.07M 0.77%
3,762
+1
+0% +$655
SJNK icon
30
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.8B
$2.07M 0.77%
86,989
+1,782
+2% +$43.9K
MET icon
31
MetLife
MET
$62.1B
$2.03M 0.76%
33,374
-2,223
-6% -$142K
IJK icon
32
iShares S&P Mid-Cap 400 Growth ETF
IJK
$11.2B
$2M 0.75%
31,769
-173
-0.5% -$11.9K
VPU
33
Vanguard Utilities ETF
VPU
$8.44B
$1.84M 0.69%
12,966
-47
-0.4% -$7.49K
VOX icon
34
Vanguard Communication Services ETF
VOX
$5.85B
$1.81M 0.68%
21,979
+335
+2% +$31.9K
XOM icon
35
ExxonMobil
XOM
$634B
$1.79M 0.67%
20,492
-15,701
-43% -$1.43M
PG icon
36
Procter & Gamble
PG
$339B
$1.77M 0.66%
14,023
-1,163
-8% -$165K
BMY icon
37
Bristol-Myers Squibb
BMY
$132B
$1.73M 0.65%
24,402
-247
-1% -$17.9K
CSCO icon
38
Cisco
CSCO
$479B
$1.69M 0.63%
42,281
-2,278
-5% -$101K
MRSH
39
Marsh
MRSH
$91.5B
$1.68M 0.63%
11,267
-201
-2% -$32.3K
DVN icon
40
Devon Energy
DVN
$47.3B
$1.67M 0.63%
27,821
+76
+0.3% +$4.72K
CVX icon
41
Chevron
CVX
$366B
$1.64M 0.62%
11,444
+32
+0.3% +$4.88K
IJJ icon
42
iShares S&P Mid-Cap 400 Value ETF
IJJ
$9.03B
$1.61M 0.6%
17,944
-167
-0.9% -$16.6K
XLK icon
43
State Street Technology Select Sector SPDR ETF
XLK
$123B
$1.59M 0.59%
26,714
-294
-1% -$20.1K
TSLA icon
44
Tesla
TSLA
$1.3T
$1.58M 0.59%
5,945
+11
+0.2% +$3.07K
GIS icon
45
General Mills
GIS
$19.7B
$1.56M 0.58%
20,313
-2,047
-9% -$156K
PJP icon
46
Invesco Pharmaceuticals ETF
PJP
$498M
$1.5M 0.56%
21,011
-226
-1% -$16.9K
LOW icon
47
Lowe's Companies
LOW
$125B
$1.48M 0.55%
7,863
-34,781
-82% -$6.77M
CI icon
48
Cigna
CI
$74.6B
$1.45M 0.54%
5,222
-337
-6% -$94.8K
RTX icon
49
RTX Corp
RTX
$301B
$1.44M 0.54%
17,593
-832
-5% -$75.3K
IRM icon
50
Iron Mountain
IRM
$36.1B
$1.4M 0.52%
31,756
-122
-0.4% -$6.16K

Similar funds

Dumont & Blake Investment Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Dumont & Blake Investment Advisors held 206 positions worth $267M, down 13% from $306M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Dumont & Blake Investment Advisors withdrew a net $24.7M in Q3 2022, closing 15 positions and reducing 101 holdings. Its most notable exit was Eli Lilly, an estimated $2.45M position sold in full.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Dumont & Blake Investment Advisors opened a new position in Charles River Laboratories worth $466K.

  • Dumont & Blake Investment Advisors's largest Q3 2022 buy was Charles River Laboratories: 2,368 shares worth $466K.
  • Dumont & Blake Investment Advisors added most to Whirlpool in Q3 2022, an estimated $164K increase.
  • Dumont & Blake Investment Advisors's biggest Q3 2022 reduction was Lowe's Companies, cutting an estimated $6.77M.
  • Dumont & Blake Investment Advisors fully exited Eli Lilly in Q3 2022, selling an estimated $2.45M.
  • Dumont & Blake Investment Advisors's ten largest holdings make up 36% of its $267M portfolio in Q3 2022.
  • Dumont & Blake Investment Advisors opened 4 new positions and closed 15 in Q3 2022.
  • Dumont & Blake Investment Advisors's portfolio value fell 13% quarter-over-quarter to $267M.

Based on Dumont & Blake Investment Advisors's 13F filing for Q3 2022, filed 24 Oct 2022.